☆ 4.5 Letter

Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer

BREAST CANCER RESEARCH AND TREATMENT (2009)

Journal

BREAST CANCER RESEARCH AND TREATMENT

Volume 118, Issue 3, Pages 651-653

Publisher

SPRINGER

DOI: 10.1007/s10549-009-0428-8

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Oncology

The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women

Alexey Larionov, Eleanor Fewings, James Redman, Mae Goldgraben, Graeme Clark, John Boice, Patrick Concannon, Jonine Bernstein, David V. Conti, Marc WECARE Study Collaborative Grp, Marc Tischkowitz

Summary: In this study, researchers used genetic sequencing technologies to investigate the hereditary causes of second breast cancer in individuals who do not have alterations in the main breast cancer genes (BRCA1, BRCA2 and PALB2). They found that younger women with second breast cancers had a higher number of inherited gene alterations compared to women with only one breast cancer. This study improves our understanding of the hereditary contribution to second breast cancers.

CANCERS (2023)

Add to Collection

Article Genetics & Heredity

High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer

Nicola Flaum, Emma J. Crosbie, Richard Edmondson, Emma R. Woodward, Fiona Lalloo, Miriam J. Smith, Helene Schlecht, D. Gareth Evans

Summary: This study reviewed the genetic testing of women with familial epithelial ovarian cancer (EOC) at a center. One-fifth of BRCA-negative women carried potentially actionable gene variants. Wider genetic testing of women with familial EOC is essential for optimizing treatment and preventing disease in family members.

GENETICS IN MEDICINE (2022)

Add to Collection

Article Genetics & Heredity

Contribution of large genomic rearrangements in PALB2 to familial breast cancer: implications for genetic testing

Na Li, Magnus Zethoven, Simone McInerny, Eliza Healey, Dilanka DeSilva, Lisa Devereux, Rodney J. Scott, Paul A. James, Ian G. Campbell

Summary: PALB2 is the most important contributor to familial breast cancer after BRCA1 and BRCA2. This study shows that a clinically important proportion of PALB2 pathogenic mutations in Australian patients with familial breast cancer are large genomic rearrangements (LGRs).

JOURNAL OF MEDICAL GENETICS (2023)

Add to Collection

Article Genetics & Heredity

UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

Helen Hanson, Anjana Kulkarni, Lucy Loong, Grace Kavanaugh, Bethany Torr, Sophie Allen, Munaza Ahmed, Antonis C. Antoniou, Ruth Cleaver, Tabib Dabir, D. Gareth Evans, Ellen Golightly, Rosalyn Jewell, Kelly Kohut, Ranjit Manchanda, Alex Murray, Jennie Murray, Kai-Ren Ong, Adam N. Rosenthal, Emma Roisin Woodward, Diana M. Eccles, Clare Turnbull, Marc Tischkowitz, Fiona Lalloo

Summary: This paper presents a summary of the process and key recommendations from a national consensus on the clinical management of BRIP1, PALB2, RAD51D, and RAD51C carriers.

JOURNAL OF MEDICAL GENETICS (2023)

Add to Collection

Article Hematology

Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms

Miriam Elbracht, Robert Meyer, Kim Kricheldorf, Deniz Gezer, Thomas Eggermann, Beate Betz, Ingo Kurth, Lino L. Teichmann, Tim H. Bruemmendorf, Ulrich Germing, Susanne Isfort, Steffen Koschmieder

Summary: The study identified germline mutations in MPNs patients, suggesting a higher risk of leukemia; the discovery of hereditary tumor predisposition is crucial for therapeutic options and preventive care for individuals with MPNs in their families.

BLOOD ADVANCES (2021)

Add to Collection

Article Genetics & Heredity

Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis

Matvey M. Tsyganov, Sofia S. Sorokovikova, Elizaveta A. Lutzkaya, Marina K. Ibragimova

Summary: This study aimed to evaluate the predictive and prognostic potential of DNA copy number aberrations and mutations in the BRCA1, BRCA2, and PALB2 genes in breast tumors. Results showed that a normal copy number of PALB2 was associated with a lack of response to chemotherapy in Taxotere-containing treatment regimens (p=0.05), and a PALB2 deletion was associated with 100% metastatic survival rates (log-rank test p=0.04). Mutations were found in the BRCA1 (25 mutations), BRCA2 (42 mutations), and PALB2 (27 mutations) genes. The effect of mutations on treatment effectiveness is controversial, but an impact on survival in breast cancer patients has been observed.

GENES (2023)

Add to Collection

Article Pathology

Small-scale variants and large deletions in BRCA1/2 genes in Slovak high-grade serous ovarian cancer

Katarina Janikova, Barbora Vanova, Marian Grendar, Marek Samec, Dusan Loderer, Maria Skerenova, Ivana Kasubova, Anna Farkasova, Karla Scheerova, Pavol Slavik, Zora Lasabova, Zuzana Dankova, Jan Strnadel, Erika Halasova, Lukas Plank

Summary: The role of PARP inhibitors is to prevent repair of single-strand breaks caused by tumor growth, leading to cell apoptosis in the absence of homologous recombination deficiency (HRD) system. This eliminated system can be monitored in patients with serous ovarian epithelial tumors. Studies show that the highest progression-free survival (PFS) is observed in groups with BRCA mutant status, although PARP inhibitors are also effective in cases with disrupted HRD system other than BRCA genes.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Staphylococcal Enterotoxin Genes in Coagulase-Negative Staphylococci-Stability, Expression, and Genomic Context

Sylwia Banaszkiewicz, Ewa Walecka-Zacharska, Justyna Schubert, Aleksandra Tabis, Jaroslaw Krol, Tadeusz Stefaniak, Ewelina Wesierska, Jacek Bania

Summary: In this study, a collection of coagulase-negative staphylococci (CoNS) isolates were screened for orthologues of staphylococcal enterotoxins (SEs) involved in Staphylococcus aureus-related staphylococcal food poisoning (SFP). The results showed that SE amplicons were detected in multiple CoNS species, but their copy numbers varied significantly. Only those SE genes with high copy numbers in stable form could be expressed at the protein level.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study

Han-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, Chih-Yi Hsu, Pei-Ju Lien, Yen-Shu Lin, Ta-Chung Chao, Jiun-I. Lai, Chin-Jung Feng, Yen-Jen Chen, Bo-Fang Chen, Jen-Hwey Chiu, Ling-Ming Tseng, Chi-Cheng Huang

Summary: The study analyzed the prevalence of genetic alterations specific to BRCA1, BRCA2, and PALB2 in Taiwanese breast cancer patients using tumor-targeted sequencing. Some patients may benefit from PARP inhibitors due to identified mutations, highlighting the importance of accurately annotating variants in cancer-related genes.

BREAST CANCER RESEARCH (2023)

Add to Collection

Article Oncology

5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints

Sandrine M. Caputo, Dominique Telly, Adrien Briaux, Julie Sesen, Maurizio Ceppi, Francoise Bonnet, Violaine Bourdon, Florence Coulet, Laurent Castera, Capucine Delnatte, Agnes Hardouin, Sylvie Mazoyer, Ines Schultz, Nicolas Sevenet, Nancy Uhrhammer, Celine Bonnet, Anne-Francoise Tilkin-Mariame, Claude Houdayer, Virginie Moncoutier, Catherine Andrieu, Ivan Bieche, Marc-Henri Stern, Dominique Stoppa-Lyonnet, Rosette Lidereau, Christine Toulas, Etienne Rouleau

Summary: Large genomic rearrangements in BRCA1, such as deletions or duplications of one or multiple exons, are often found in the 5' region. Breakpoint localization helps understand chromatin structure in rearrangement-sensitive regions. Some rearrangement events are not necessarily harmful.

CANCERS (2021)

Add to Collection

Article Genetics & Heredity

Sequencing individual genomes with recurrent genomic disorder deletions: an approach to characterize genes for autosomal recessive rare disease traits

Bo Yuan, Katharina V. Schulze, Nurit Assia Batzir, Jefferson Sinson, Hongzheng Dai, Wenmiao Zhu, Francia Bocanegra, Chin-To Fong, Jimmy Holder, Joanne Nguyen, Christian P. Schaaf, Yaping Yang, Weimin Bi, Christine Eng, Chad Shaw, James R. Lupski, Pengfei Liu

Summary: This article introduces a segmental haploid genetics approach to enhance gene discovery and molecular diagnostics. By constructing a genome-wide map, estimating the population frequencies of nonallelic homologous recombination (NAHR) deletions, calculating recessive disease carrier burden, and developing a NAHR deletion Impact to Recessive Disease (NIRD) score, the study demonstrates that genomic sequencing of personal genomes with NAHR deletions can dramatically improve allele and gene discovery and enhance clinical molecular diagnosis.

GENOME MEDICINE (2022)

Add to Collection

Article Oncology

Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome

Lin Dong, Shuangmei Zou, Xianglan Jin, Haizhen Lu, Ye Zhang, Lei Guo, Jianqiang Cai, Jianming Ying

Summary: This study identified rare cytoplasmic MSH2 staining in CRC patients, some of whom had LS with pathogenic mutations in MSH2 and/or EPCAM, including large genomic rearrangements. Analysis revealed novel RNA fusions and deletions of EPCAM and MSH2, originating from Alu repeat-mediated recombination events. Clinical evidence supported the beneficial effect of PD-1 inhibitor pembrolizumab in CRC patients with cytoplasmic MSH2 staining.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Hematology

Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all

Roland P. Kuiper, Patricia G. Hoogeveen, Reno Bladergroen, Freerk van Dijk, Edwin Sonneveld, Frank N. van Leeuwen, Judith Boer, Irina Sergeeva, Harma Feitsma, Monique L. den Boer, Vincent H. J. van der Velden

Summary: The study revealed that fusion genes and genomic deletions can be used as alternative MRD targets in ALL patients who do not have sensitive IG/TR targets, leading to appropriate patient stratification and potentially impacting treatment decisions.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Oncology

Adolescent triple-negative breast cancer with germline pathogenic variants in both BRCA1 and TP53 genes: A case report

Dongmei Chen, Chenyang Zhang, Mengqi Yuan, Ying Zhang, Qing Liu, Donggui Wan

Summary: This article reports a case of a 14-year-old female with triple-negative breast cancer and a family history of malignant tumors. The case highlights the importance of genetic testing in early onset breast cancer to confirm inherited risk and recommends genetic testing for relatives.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Genetics & Heredity

Identification of CHEK2 Germline Mutations in BRCA1/2- and PALB2-Negative Breast and Ovarian Cancer Patients

Fuat Aksoy, Havva Tezcan Unlu, Gulsah Cecener, Gamze Guney Eskiler, Unal Egeli, Berrin Tunca, Ecem Efendi Erdem, Kazim Senol, Mustafa Sehsuvar Gokgoz

Summary: This study identified 16 CHEK2 gene variants in the Turkish population, and found a 7.3% prevalence of variants of uncertain significance in BRCA1/2 and PALB2 mutation-negative Turkish patients with early-onset breast and/or ovarian cancer. These findings may provide insights into the clinical relevance of CHEK2 gene variations.

HUMAN HEREDITY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Second case of Bardet-Biedl syndrome caused by biallelic variants in IFT74

Lotte Kleinendorst, Sanne I. M. Alsters, Ozair Abawi, Quinten Waisfisz, Elles M. J. Boon, Erica L. T. van den Akker, Mieke M. van Haelst

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Add to Collection

Article Medicine, Research & Experimental

Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability

Lin Li, Mohammad Ghorbani, Monika Weisz-Hubshman, Justine Rousseau, Isabelle Thiffault, Rhonda E. Schnur, Catherine Breen, Renske Oegema, Marjan M. M. Weiss, Quinten Waisfisz, Sara Welner, Helen Kingston, Jordan A. Hills, Elles M. J. Boon, Lina Basel-Salmon, Osnat Konen, Hadassa Goldberg-Stern, Lily Bazak, Shay Tzur, Jianliang Jin, Xiuli Bi, Michael Bruccoleri, Kirsty McWalter, Megan T. Cho, Maria Scarano, G. Bradley Schaefer, Susan S. Brooks, Susan Starling Hughes, K. L. van Gassen, Johanna M. van Hagen, Tej K. Pandita, Pankaj B. Agrawal, Philippe M. Campeau, Xiang-Jiao Yang

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Genetics & Heredity

Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing

Anna Fliedner, Philipp Kirchner, Antje Wiesener, Irma van de Beek, Quinten Waisfisz, Mieke van Haelst, Daryl A. Scott, Seema R. Lalani, Jill A. Rosenfeld, Mahshid S. Azamian, Fan Xia, Marina Dutra-Clarke, Julian A. Martinez-Agosto, Hane Lee, Grace J. Noh, Natalie Lippa, Anna Alkelai, Vimla Aggarwal, Katherine E. Agre, Ralitza Gavrilova, Ghayda M. Mirzaa, Rachel Straussberg, Rony Cohen, Brooke Horist, Vidya Krishnamurthy, Kirsty McWalter, Jane Juusola, Laura Davis-Keppen, Lisa Ohden, Marjon van Slegtenhorst, Stella A. de Man, Arif B. Ekici, Anne Gregor, Ingrid van de Laar, Christiane Zweierl

AMERICAN JOURNAL OF HUMAN GENETICS (2020)

Add to Collection

Article Genetics & Heredity

Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum

Marialetizia Motta, Luca Pannone, Francesca Pantaleoni, Gianfranco Bocchinfuso, Francesca Clementina Radio, Serena Cecchetti, Andrea Ciolfi, Martina Di Rocco, Mariet W. Elting, Eva H. Brilstra, Stefania Boni, Laura Mazzanti, Federica Tamburrino, Larry Walsh, Katelyn Payne, Alberto Fernandez-Jaen, Mythily Ganapathi, Wendy K. Chung, Dorothy K. Grange, Ashita Dave-Wala, Shalini C. Reshmi, Dennis W. Bartholomew, Danielle Mouhlas, Giovanna Carpentieri, Alessandro Bruselles, Simone Pizzi, Emanuele Bellacchio, Francesca Piceci-Sparascio, Christina Lissewski, Julia Brinkmann, Ronald R. Waclaw, Quinten Waisfisz, Koen van Gassen, Ingrid M. Wentzensen, Michelle M. Morrow, Sara Alvarez, Monica Martinez-Garcia, Alessandro De Luca, Luigi Memo, Giuseppe Zampino, Cesare Rossi, Marco Seri, Bruce D. Gelb, Martin Zenker, Bruno Dallapiccola, Lorenzo Stella, Carlos E. Prada, Simone Martinelli, Elisabetta Flex, Marco Tartaglia

AMERICAN JOURNAL OF HUMAN GENETICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Whole-genome sequencing of patients with rare diseases in a national health system

Ernest Turro, William J. Astle, Karyn Megy, Stefan Graef, Daniel Greene, Olga Shamardina, Hana Lango Allen, Alba Sanchis-Juan, Mattia Frontini, Chantal Thys, Jonathan Stephens, Rutendo Mapeta, Oliver S. Burren, Kate Downes, Matthias Haimel, Salih Tuna, Sri V. V. Deevi, Timothy J. Aitman, David L. Bennett, Paul Calleja, Keren Carss, Mark J. Caulfield, Patrick F. Chinnery, Peter H. Dixon, Daniel P. Gale, Roger James, Ania Koziell, Michael A. Laffan, Adam P. Levine, Eamonn R. Maher, Hugh S. Markus, Joannella Morales, Nicholas W. Morrell, Andrew D. Mumford, Elizabeth Ormondroyd, Stuart Rankin, Augusto Rendon, Sylvia Richardson, Irene Roberts, Noemi B. A. Roy, Moin A. Saleem, Kenneth G. C. Smith, Hannah Stark, Rhea Y. Y. Tan, Andreas C. Themistocleous, Adrian J. Thrasher, Hugh Watkins, Andrew R. Webster, Martin R. Wilkins, Catherine Williamson, James Whitworth, Sean Humphray, David R. Bentley, Nathalie Kingston, Neil Walker, John R. Bradley, Sofie Ashford, Christopher J. Penkett, Kathleen Freson, Kathleen E. Stirrups, F. Lucy Raymond, Willem H. Ouwehand

NATURE (2020)

Add to Collection

Article Genetics & Heredity

Interaction between KDELR2 and HSP47 as a Key Determinant in Osteogenesis Imperfecta Caused by Bi-allelic Variants in KDELR2

Fleur S. van Dijk, Oliver Semler, Julia Etich, Anna Koehler, Juan A. Jimenez-Estrada, Nathalie Bravenboer, Lauria Claeys, Elise Riesebos, Sejla Gegic, Sander R. Piersma, Connie R. Jimenez, Quinten Waisfisz, Carmen-Lisset Flores, Julian Nevado, Arjan J. Harsevoort, Guus J. M. Janus, Anton A. M. Franken, Astrid M. van der Sar, Hanne Meijers-Heijboer, Karen E. Heath, Pablo Lapunzina, Peter G. J. Nikkels, Gijs W. E. Santen, Julian Nuechel, Markus Plomann, Raimund Wagener, Mirko Rehberg, Heike Hoyer-Kuhn, Elisabeth M. W. Eekhoff, Gerard Pals, Matthias Morgelin, Simon Newstead, Brian T. Wilson, Victor L. Ruiz-Perez, Alessandra Maugeri, Christian Netzer, Frank Zaucke, Dimitra Micha

AMERICAN JOURNAL OF HUMAN GENETICS (2020)

Add to Collection

Article Genetics & Heredity

Germline variants inHEY2functional domains lead to congenital heart defects and thoracic aortic aneurysms

Eva S. van Walree, Gregor Dombrowsky, Iris E. Jansen, Masa Umicevic Mirkov, Rob Zwart, Aho Ilgun, Dongchuan Guo, Sally-Ann B. Clur, Ahmed S. Amin, Jeanne E. Savage, Allard C. van der Wal, Quinten Waisfisz, Alessandra Maugeri, Anna Wilsdon, Frances A. Bu'Lock, Matthew E. Hurles, Sven Dittrich, Felix Berger, Enrique Audain Martinez, Vincent M. Christoffels, Marc-Philip Hitz, Dianna M. Milewicz, Danielle Posthuma, Hanne Meijers-Heijboer, Alex V. Postma, Inge B. Mathijssen

Summary: The study identified a loss-of-function variant in the HEY2 gene associated with cardiovascular defects, with heterozygous carriers and homozygous patients showing varying degrees of heart diseases.

GENETICS IN MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders

Fanny Mochel, Agnes Rastetter, Berten Ceulemans, Konrad Platzer, Sandra Yang, Deepali N. Shinde, Katherine L. Helbig, Diego Lopergolo, Francesca Mari, Alessandra Renieri, Elisa Benetti, Roberto Canitano, Quinten Waisfisz, Astrid S. Plomp, Sylvia A. Huisman, Golder N. Wilson, Sara S. Cathey, Raymond J. Louie, Daniela Del Gaudio, Darrel Waggoner, Shawn Kacker, Kimberly M. Nugent, Elizabeth R. Roeder, Ange-Line Bruel, Julien Thevenon, Nadja Ehmke, Denise Horn, Manuel Holtgrewe, Frank J. Kaiser, Susanne B. Kamphausen, Rami Abou Jamra, Sarah Weckhuysen, Carine Dalle, Christel Depienne

BRAIN (2020)

Add to Collection

Article Genetics & Heredity

An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

Sacha Ferdinandusse, Kirsty McWalter, Heleen te Brinke, Lodewijk Ijlst, Petra M. Mooijer, Jos P. N. Ruiter, Alida E. M. van Lint, Mia Pras-Raves, Eric Wever, Francisca Millan, Maria J. Guillen Sacoto, Amber Begtrup, Mark Tarnopolsky, Lauren Brady, Roger L. Ladda, Susan L. Sell, Catherine B. Nowak, Jessica Douglas, Cuixia Tian, Elizabeth Ulm, Seth Perlman, Arlene V. Drack, Karen Chong, Nicole Martin, Jennifer Brault, Elly Brokamp, Camilo Toro, William A. Gahl, Ellen F. Macnamara, Lynne Wolfe, Quinten Waisfisz, Petra J. G. Zwijnenburg, Alban Ziegler, Magalie Barth, Rosemarie Smith, Sara Ellingwood, Deborah Gaebler-Spira, Somayeh Bakhtiari, Michael C. Kruer, Antoine H. C. van Kampen, Ronald J. A. Wanders, Hans R. Waterham, David Cassiman, Frederic M. Vaz

Summary: The study found that de novo variants affecting the Arg480 residue of FAR1 lead to an autosomal dominant disorder with a different disease mechanism than that of recessive FAR1 deficiency. FAR1 deficiency causes defective ether lipid synthesis, while the de novo variants result in elevated plasmalogen levels. Further functional studies in fibroblasts revealed disruption of plasmalogen-dependent feedback regulation of FAR1 protein levels.

GENETICS IN MEDICINE (2021)

Add to Collection

Article Physiology

Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases

Valeria Rizzuto, Tamara T. Koopmann, Adoracion Blanco-Alvarez, Barbara Tazon-Vega, Amira Idrizovic, Cristina Diaz de Heredia, Rafael Del Orbe, Miriam Vara Pampliega, Pablo Velasco, David Beneitez, Gijs W. E. Santen, Quinten Waisfisz, Mariet Elting, Frans J. W. Smiers, Anne J. de Pagter, Jean-Louis H. Kerkhoffs, Cornelis L. Harteveld, Maria del Mar Manu-Pereira

Summary: Unstable hemoglobinopathies (UHs) are rare anemia disorders characterized by abnormal hemoglobin variants with decreased stability, easily causing hemolysis. Diagnosis of UHs requires a high index of suspicion by the treating physician, highlighting the importance of next generation sequencing (NGS) methodologies.

FRONTIERS IN PHYSIOLOGY (2021)

Add to Collection

Article Clinical Neurology

Homozygous UBA5 Variant Leads to Hypomyelination with Thalamic Involvement and Axonal Neuropathy

Murtadha L. Al-Saady, Charlotte S. Kaiser, Felipe Wakasuqui, G. Christoph Korenke, Quinten Waisfisz, Abeltje Polstra, Petra J. W. Pouwels, Marianna Bugiani, Marjo S. van der Knaap, Roelineke J. Lunsing, Eva Liebau, Nicole I. Wolf

Summary: The study found that the enzyme UBA5 plays a crucial role in neurodevelopmental disorders, especially in early-onset epileptic encephalopathy. A homozygous UBA5 variant was detected in a patient with severe global developmental delay and epilepsy, leading to insights into the impact of this variant on UBA5 protein function. The findings suggest that epilepsy associated with UBA5 variants may manifest later in life than previously thought, and radiological signs may include hypomyelination and thalamic involvement.

NEUROPEDIATRICS (2021)

Add to Collection

Correction Genetics & Heredity

Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome (vol 103, pg 431, 2018)

Shereen G. Ghosh, Kerstin Becker, He Huang, Tracy D. Salazar, Guoliang Chai, Vincenzo Salpietro, Lihadh Al-Gazali, Quinten Waisfisz, Haicui Wang, Keith K. Vaux, Valentina Stanley, Andreea Manole, Ugur Akpulat, Marjan M. Weiss, Stephanie Efthymiou, Michael G. Hanna, Carlo Minetti, Pasquale Striano, Livia Pisciotta, Elisa De Grandis, Janine Altmuller, Lisa Weixler, Peter Nurnberg, Holger Thiele, Uluc Yis, Tuncay Derya Okur, Ayse Ipek Polat, Nafise Amiri, Mohammad Doosti, Ehsan Ghayoor Karimani, Mehran B. Toosi, Gabriel Haddad, Mert Karakaya, Brunhilde Wirth, Johanna M. van Hagen, Nicole I. Wolf, Reza Maroofian, Henry Houlden, Sebahattin Cirak, Joseph G. Gleeson

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Add to Collection

Correction Genetics & Heredity

An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (vol 23, pg 740, 2021)

Sacha Ferdinandusse, Kirsty McWalter, Heleen te Brinke, Lodewijk Ijlst, Petra M. Mooijer, Jos P. N. Ruiter, Alida E. M. van Lint, Mia Pras-Raves, Eric Wever, Francisca Millan, Maria J. Guillen Sacoto, Amber Begtrup, Mark Tarnopolsky, Lauren Brady, Roger L. Ladda, Susan L. Sell, Catherine B. Nowak, Jessica Douglas, Cuixia Tian, Elizabeth Ulm, Seth Perlman, Arlene V. Drack, Karen Chong, Nicole Martin, Jennifer Brault, Elly Brokamp, Camilo Toro, William A. Gahl, Ellen F. Macnamara, Lynne Wolfe, Quinten Waisfisz, Petra J. G. Zwijnenburg, Alban Ziegler, Magalie Barth, Rosemarie Smith, Sara Ellingwood, Deborah Gaebler-Spira, Somayeh Bakhtiari, Michael C. Kruer, Antoine H. C. van Kampen, Ronald J. A. Wanders, Hans R. Waterham, David Cassiman, Frederic M. Vaz

GENETICS IN MEDICINE (2021)

Add to Collection

Review Genetics & Heredity

Fetal akinesia deformation sequence and massive perivillous fibrin deposition resulting in fetal death in six fetuses from one consanguineous couple, including literature review

Jill K. Tjon, Phillis Lakeman, Elisabeth van Leeuwen, Quinten Waisfisz, Marjan M. Weiss, Gita M. B. Tan-Sindhunata, Peter G. J. Nikkels, Patrick J. P. van der Voorn, Gajja S. Salomons, George L. Burchell, Ingeborg H. Linskens, Bloeme J. van der Knoop, Johanna I. P. de Vries

Summary: This study reported a consanguineous couple with six fetuses developing Fetal Akinesia Deformation Sequence (FADS) and MPFD, possibly due to a genetic cause. The literature review found a low prevalence of FADS and MPFD cases, supporting the conclusion that multiple factors (fetal, fetoplacental, genetic) may contribute to causing MPFD.

MOLECULAR GENETICS & GENOMIC MEDICINE (2021)

Add to Collection

Letter Oncology

Dynamic clonal hematopoiesis and functional T-cell immunity in a supercentenarian

Erik B. van den Akker, Stavros Makrodimitris, Marc Hulsman, Martijn H. Brugman, Tatjana Nikolic, Ted Bradley, Quinten Waisfisz, Frank Baas, Marja E. Jakobs, Daphne de Jong, P. Eline Slagboom, Frank J. T. Staal, Marcel J. T. Reinders, Henne Holstege

LEUKEMIA (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.